Harnessing lipid nanoparticles for efficient CRISPR delivery

Jingyue Yan; Diana D. Kang; Yizhou Dong

doi:10.1039/d1bm00537e

Harnessing lipid nanoparticles for efficient CRISPR delivery

Jingyue Yan, Diana D. Kang, Yizhou Dong

Research output: Contribution to journal › Review article › peer-review

45 Scopus citations

Abstract

The CRISPR-Cas system has revolutionized the biomedical research field with its simple and flexible genome editing method. In October 2020, Emmanuelle Charpentier and Jennifer A. Doudna were awarded the 2020 Nobel Prize in chemistry in recognition of their outstanding contributions to the discovery of CRISPR-Cas9 genetic scissors, which allow scientists to alter DNA sequences with high precision. Recently, the first phase I clinical trials in cancer patients affirmed the safety and feasibility of ex vivo CRISPR-edited T cells. However, specific and effective CRISPR delivery in vivo remains challenging due to the multiple extracellular and intracellular barriers. Here, we discuss the recent advances in novel lipid nanomaterials for CRISPR delivery and describe relevant examples of potential therapeutics in cancers, genetic disorders, and infectious diseases.

Original language	English
Pages (from-to)	6001-6011
Number of pages	11
Journal	Biomaterials Science
Volume	9
Issue number	18
DOIs	https://doi.org/10.1039/d1bm00537e
State	Published - 21 Sep 2021
Externally published	Yes

Access to Document

10.1039/d1bm00537e

Cite this

@article{5fe6d99fa48044a986d22c8c450dc153,

title = "Harnessing lipid nanoparticles for efficient CRISPR delivery",

abstract = "The CRISPR-Cas system has revolutionized the biomedical research field with its simple and flexible genome editing method. In October 2020, Emmanuelle Charpentier and Jennifer A. Doudna were awarded the 2020 Nobel Prize in chemistry in recognition of their outstanding contributions to the discovery of CRISPR-Cas9 genetic scissors, which allow scientists to alter DNA sequences with high precision. Recently, the first phase I clinical trials in cancer patients affirmed the safety and feasibility of ex vivo CRISPR-edited T cells. However, specific and effective CRISPR delivery in vivo remains challenging due to the multiple extracellular and intracellular barriers. Here, we discuss the recent advances in novel lipid nanomaterials for CRISPR delivery and describe relevant examples of potential therapeutics in cancers, genetic disorders, and infectious diseases.",

author = "Jingyue Yan and Kang, {Diana D.} and Yizhou Dong",

note = "Publisher Copyright: {\textcopyright} 2021 The Royal Society of Chemistry.",

year = "2021",

month = sep,

day = "21",

doi = "10.1039/d1bm00537e",

language = "English",

volume = "9",

pages = "6001--6011",

journal = "Biomaterials Science",

issn = "2047-4830",

publisher = "Royal Society of Chemistry",

number = "18",

}

TY - JOUR

T1 - Harnessing lipid nanoparticles for efficient CRISPR delivery

AU - Yan, Jingyue

AU - Kang, Diana D.

AU - Dong, Yizhou

PY - 2021/9/21

Y1 - 2021/9/21

N2 - The CRISPR-Cas system has revolutionized the biomedical research field with its simple and flexible genome editing method. In October 2020, Emmanuelle Charpentier and Jennifer A. Doudna were awarded the 2020 Nobel Prize in chemistry in recognition of their outstanding contributions to the discovery of CRISPR-Cas9 genetic scissors, which allow scientists to alter DNA sequences with high precision. Recently, the first phase I clinical trials in cancer patients affirmed the safety and feasibility of ex vivo CRISPR-edited T cells. However, specific and effective CRISPR delivery in vivo remains challenging due to the multiple extracellular and intracellular barriers. Here, we discuss the recent advances in novel lipid nanomaterials for CRISPR delivery and describe relevant examples of potential therapeutics in cancers, genetic disorders, and infectious diseases.

AB - The CRISPR-Cas system has revolutionized the biomedical research field with its simple and flexible genome editing method. In October 2020, Emmanuelle Charpentier and Jennifer A. Doudna were awarded the 2020 Nobel Prize in chemistry in recognition of their outstanding contributions to the discovery of CRISPR-Cas9 genetic scissors, which allow scientists to alter DNA sequences with high precision. Recently, the first phase I clinical trials in cancer patients affirmed the safety and feasibility of ex vivo CRISPR-edited T cells. However, specific and effective CRISPR delivery in vivo remains challenging due to the multiple extracellular and intracellular barriers. Here, we discuss the recent advances in novel lipid nanomaterials for CRISPR delivery and describe relevant examples of potential therapeutics in cancers, genetic disorders, and infectious diseases.

UR - http://www.scopus.com/inward/record.url?scp=85115190416&partnerID=8YFLogxK

U2 - 10.1039/d1bm00537e

DO - 10.1039/d1bm00537e

M3 - Review article

C2 - 34115079

AN - SCOPUS:85115190416

SN - 2047-4830

VL - 9

SP - 6001

EP - 6011

JO - Biomaterials Science

JF - Biomaterials Science

IS - 18

ER -

Harnessing lipid nanoparticles for efficient CRISPR delivery

Abstract

Access to Document

Fingerprint

Cite this